The Academy of Translational Medicine is an innovation hub to connect people from diverse sectors in science, business, health and government to accelerate the translation of scientific discoveries into clinical practice to create a more sustainable health care system.
“The ATM helped us devise a regulatory plan for the project and satisfy the regulatory affairs requirements in our NFRF application. This support was important for securing the NFRF funding and with so many moving parts to this project, it is amazing to have access to group of regulatory experts as we move forward.”– Dr. John Madden, Director of the Mend the Gap team that recently secured $24M in funding from the New Frontiers in Research Fund (NFRF)
“The new education programs in the ATM are meeting urgent needs for better knowledge and training in entrepreneurship at the intersection of science and business. Collaborative programs like these are crucial if we are to dramatically reduce cycle times from lab discovery to patient impact and fulfill the ambition to make UBC and Vancouver a global life science innovation hub.”– Paul Cubbon, Assistant Dean of Innovation, UBC Sauder School of Business and CDL-Vancouver Lead at Creative Destruction Lab ATM Entrepreneurship course
We are delighted to announce the appointment of Dr. Dean Regier as Co-Director pro tem for the Academy of Translational Medicine (ATM) while Dr. Poul Sorensen is on sabbatical at Technical University of Munich.
The Faculty of Medicine (FoM) has announced Round #2 of the Academic Renewal Program. UBC centrally provides 80% of the funding for this program for new faculty positions focused in the areas of translational science and medicine, data science, and virtual/rural and remote health. This round will be same as previous one with 6 junior faculty positions available for competition.
The award, given every year by the Connective Tissue Oncology Society, recognizes outstanding contributions to the basic science of sarcomas, especially research that translates into clinical benefits for patients. Sarcomas are malignant tumours of the connective tissues. […]
Dr. Poul Sorensen, Professor of Pathology and Laboratory Medicine and Director of the Academy of Translational Medicine (ATM) at UBC, is taking a short 4-month sabbatical at Technical University Munich (TUM) in the Southern German city to gain insights into how the German system supports translational medical research.
The silver-based coating could be applied to many different medical products.
The ATM is excited to announce that its proposal, Mini entrepreneurship-portfolio to kickstart a translational medicine education platform, has been awarded $100,562 by UBC Faculty of Medicine’s Strategic Investment Fund (SIF).
